Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.
about
A phase 1 study of ACE-536, a regulator of erythroid differentiation, in healthy volunteers.Pharmacodynamic Model of Hepcidin Regulation of Iron Homeostasis in Cynomolgus MonkeysThe ESA scenario gets complex: from biosimilar epoetins to activin traps.Pharmacokinetic and pharmacodynamic considerations on the erythropoietin effect and adverse events of darbepoetin.Biosimilar erythropoiesis-stimulating agents and the risk of developing anti-drug antibodies-a systematic review.A cell-level model of pharmacodynamics-mediated drug disposition.Assessment of hemoglobin responsiveness to epoetin alfa in patients on hemodialysis using a population pharmacokinetic pharmacodynamic model.
P2860
Q34235483-29A52726-EB84-4D7B-AC5E-43F129C207A1Q37600377-BF2C1A65-D300-4559-990D-AEE923892329Q38205752-3318113B-D37A-4DB6-8407-0988A875A6C9Q38281535-11EDB82B-CD06-42E3-8BE5-043C196A773DQ38904887-8547C88A-45BB-4E9C-A9C8-37FB02EA569DQ39406092-18C58E78-620C-4389-A3F4-AD8E401F9994Q41021058-C76BC9DE-755B-4905-A73D-7229156CA793
P2860
Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.
@en
type
label
Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.
@en
prefLabel
Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.
@en
P2093
P2860
P1476
Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.
@en
P2093
Andrew Chow
Juan José Pérez-Ruixo
Sameer Doshi
Steven Elliott
Wojciech Krzyzanski
P2860
P2888
P304
P356
10.1007/S40262-013-0098-X
P577
2013-12-01T00:00:00Z
P6179
1042101356